Literature DB >> 600312

Presynaptic dopamine receptors. Development of supersensitivity following treatment with fluphenazine decanoate.

M C Nowycky, R H Roth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 600312

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  22 in total

1.  Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol.

Authors:  G Gianutsos; M D Hynes; H Lal
Journal:  Biochem Pharmacol       Date:  1975-03-01       Impact factor: 5.858

2.  Acute and subacute effects of neuroleptics dopamine synthesis and release in the rat striatum.

Authors:  B Scatton; C Garret; L Julou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  A model for the quantitative study of central dopaminergic and serotoninergic activity.

Authors:  D Bieger; L Larochelle; O Hornykiewicz
Journal:  Eur J Pharmacol       Date:  1972-04       Impact factor: 4.432

4.  Evidence for a new type of dopamine receptor stimulating agent.

Authors:  H Corrodi; K Fuxe; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

5.  The pharmacology of tardive dyskinesias.

Authors:  H L Klawans
Journal:  Am J Psychiatry       Date:  1973-01       Impact factor: 18.112

6.  Pharmacologically induced behavioural supersensitivity to apomorphine.

Authors:  D Tarsy; R J Baldessarini
Journal:  Nat New Biol       Date:  1973-10-31

7.  Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptis.

Authors:  B Fjalland; I Moller Nielsen
Journal:  Psychopharmacologia       Date:  1974-01-11

Review 8.  Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.

Authors:  J Glowinski
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1975

9.  Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow.

Authors:  J R Walters; R H Roth
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

10.  The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum.

Authors:  T C Westfall; M J Besson; M F Giorguieff; J Glowinski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000
View more
  17 in total

1.  Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers.

Authors:  Tanja Veselinović; Holger Schorn; Ingo Vernaleken; Katharina Schiffl; Christoph Hiemke; Gerald Zernig; Ruben Gur; Gerhard Gründer
Journal:  Psychopharmacology (Berl)       Date:  2011-06-04       Impact factor: 4.530

2.  Role of dopaminergic neurotransmission in locomotor stimulation by dexamphetamine and ethanol.

Authors:  U H Strömbom; B Liedman
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.

Authors:  A Reches; V Jackson-Lewis; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Response changes after repeated low apomorphine: dopamine autoreceptor desensitization or learning?

Authors:  V J Nickolson; H van Riezen; A M van Delft
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Supersensitivity of dopamine-autoreceptors. The effect of gammabutyrolactone in long-term haloperidol treated rats.

Authors:  G Stock; J Steinbrenner; P Kummer
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

6.  Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain.

Authors:  A Reches; H R Wagner; A I Barkai; V Jackson; E Yablonskaya-Alter; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.

Authors:  A I Barkai; S Kowalik; A Reches
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.

Authors:  S C Wheeler; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

9.  Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain.

Authors:  Z S Herman; M Huzarska; K Kmieciak-Kolada; J Kowalski
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.

Authors:  M G Feenstra; C Sumners; J H Goedemoed; J B de Vries; H Rollema; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.